Clinical Trials Directory

Trials / Unknown

UnknownNCT02309970

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

CT perfusion (CTP) of the brain is an innovative technique to identify rapidly regions which are only partially or insufficiently perfused during an acute ischemic event. The differentiation between the core infarct and the still viable penumbra is its major clinical application. CTP helps directly in the decision-making process in the event of acute ischemic stroke by increasing the potential of success in patient who can benefit from thrombolytic/endovascular treatment. The use of CTP in patient selection for thrombolytic/endovascular treatment was never evaluated in a prospective randomized study. Yet, clinical experience well demonstrated a good correlation between the size of the penumbra and the clinical outcome when done in early as well as late stages of the event. The importance of identifying the penumbra in the acute phase of the ischemic stroke is widely accepted. But crucial evidence to support the predictive value of CTP to predict the clinical and anatomical/structural outcomes in the late phases (90 days after) is lacking. Currently, the use of CTP is based on theoretical assumptions and expert opinions but a randomized prospective study to validate its use is lacking. The current guidelines restrict the use of CTP trials and to patients that can't performed MRI scan.

Conditions

Interventions

TypeNameDescription
DRUGacetylsalicylic acid, clopidogrel bisulfate and/or warfarin, Apixaban, Rivaroxaban, Dabigatransubject in this group will receive oral treatment with anti platelet drug
DRUGalteplasesubject in this group will receive intravenous tPA
PROCEDUREendovascular

Timeline

Start date
2014-12-01
Primary completion
2015-12-01
Completion
2016-03-01
First posted
2014-12-05
Last updated
2014-12-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02309970. Inclusion in this directory is not an endorsement.